Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0002100119-26-001561·VANGUARD CAPITAL MANAGEMENT LLC
Schedule 13G ownership disclosure
ELEDON PHARMACEUTICALS INC COM
Common Stock · CUSIP: 28617K101
Event date: 2026-09-30
- Filing-level shares
- 3,957,862
- Percent of class
- 4.87%
- Vanguard Capital Management
Shares: 3,957,862 · Class: 4.87%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002100119-26-001561
- Form type
- SCHEDULE 13G/A
- Filer
- VANGUARD CAPITAL MANAGEMENT LLC
- CIK
- CIK 2100119
- Filed
- Oct 30, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership